The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in ...
read more
Merck announced that the European Commission (EC) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with platinum-containing ...
read more
CSL Vifor announced that its partner Akebia Therapeutics, Inc. has received FDA approval for Vafseo (vadadustat) tablets for the treatment of anemia ...
read more
Astellas Pharma Inc. announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the...
read more
Merck announced that the FDA approved sotatercept-csrk (U.S. Brand Name: WINREVAIR™, for injection, 45mg, 60mg) for the treatment of adults with ...
read more
Wednesday, March 27, 2024
Recipharm, a global leader in contract development and manufacturing, has announced two major milestones as part of its ongoing commitment to ...
read more
Wednesday, March 27, 2024
ProBioGen, a globally recognized and experienced Contract Development & Manufacturing Organization (CDMO), proudly announces a partnership with ...
read more
Wednesday, March 27, 2024
Natoli Engineering, the world-renowned leader in tablet compression tooling, presses, machine parts, and encapsulation, is excited to announce the ...
read more
Wednesday, March 27, 2024
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle ...
read more
Astellas Pharma Inc. announced that Japan's Ministry of Health, Labour and Welfare (MHLW) approved VYLOY™ (zolbetuximab), an anti-claudin 18.2 (CLDN18...
read more
FDA’s Center for Drug Evaluation and Research (CDER) has announced the new Quantitative Medicine (QM) Center of Excellence (CoE).
read more
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalized medicine.
read more
Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the treatment ...
read more
Esperion announced that the FDA approved broad new label expansions for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe...
read more
The U.S. Food and Drug Administration approved Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy (DMD) in patients...
read more